文献速递重症综合管理与镇静镇痛

重症监护幸存者心理困扰的移动正念干预:一项随机临床试验

Mobile Mindfulness Intervention for Psychological Distress Among Intensive Care Unit Survivors: A Randomized Clinical Trial.
PubMed 文献 · JAMA Intern Med · 2024-01-01
一句话结论在重症监护幸存者中,每日两次冥想较每日一次与1个月PHQ-9评分降低1.2分相关,作者认为含应用程序介绍、每日两次引导冥想和应用程序管理症状的版本最优。

这项2×2×2析因随机临床试验在3个中心纳入247例出院后抑郁症状升高的重症监护幸存者,比较正念干预的三种两组分组合:介绍方式(移动应用程序 vs 治疗师电话)、冥想剂量(每日一次 vs 每日两次)、症状加重管理方式(移动应用程序 vs 治疗师电话)。主要终点为1个月时PHQ-9抑郁评分。结果显示,每日两次冥想较每日一次与1个月PHQ-9评分降低1.2分(95%CI 0.04-2.4)、3个月降低1.5分(95%CI 0.1-2.8)相关;另外两个组分对PHQ-9无主效应。作者结论认为,包含应用程序介绍、每日两次引导冥想和应用程序管理抑郁症状加重的版本在心理困扰症状、依从性和可行性方面最优。

要点

  • 每日两次冥想较每日一次与1个月PHQ-9评分降低1.2分(95%CI 0.04-2.4)相关。
  • 每日两次冥想较每日一次与3个月PHQ-9评分降低1.5分(95%CI 0.1-2.8)相关。
  • 介绍方式(移动应用程序 vs 治疗师电话)和症状加重管理方式(移动应用程序 vs 治疗师电话)对PHQ-9无主效应。
  • 总体依从性高:217例(87.9%)在试验结束时仍在使用干预。
  • 保留率高:1个月时191例(77.3%),3个月时182例(73.7%)。

适用人群与场景

  • 3个中心的重症监护幸存者,出院后抑郁症状升高。
  • 研究于2019年8月至2023年7月进行。

处置流程与药物剂量

  • 干预包含三个两组分:介绍方式(移动应用程序 vs 治疗师电话)、冥想剂量(每日一次 vs 每日两次)、症状加重管理方式(移动应用程序 vs 治疗师电话)。
  • 参与者被随机分配到8个不同组别之一,对应上述三种两组分干预组合。

研究设计与关键结果

  • 研究类型:2×2×2析因随机临床试验,3个中心,247例参与者(平均[SD]年龄50.2[15.4]岁;104例[42.1%]女性)。
  • 主要终点:1个月时9项患者健康问卷(PHQ-9)抑郁量表评分(范围0-27)。
  • 每日两次冥想较每日一次与1个月PHQ-9估计平均评分降低1.2分(95%CI 0.04-2.4)相关。
  • 每日两次冥想较每日一次与3个月PHQ-9估计平均评分降低1.5分(95%CI 0.1-2.8)相关。
  • 另外两个干预组分对PHQ-9无主效应。
  • 依从性:217例(87.9%)在试验结束时仍在使用干预;保留率:1个月191例(77.3%),3个月182例(73.7%)。

证据类型、等级与局限

  • 证据类型:随机临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,包含应用程序介绍、每日两次引导冥想和应用程序管理抑郁症状加重的正念干预版本,在考虑心理困扰症状、依从性和可行性方面最优。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Although psychological distress is common among survivors of critical illness, there are few tailored therapies.

OBJECTIVE: To determine the optimal method for delivering a mindfulness intervention via a mobile app for critical illness survivors.

DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial used a 2 × 2 × 2 factorial design and was conducted at 3 sites among survivors of critical illness with elevated postdischarge symptoms of depression. The study was conducted between August 2019 and July 2023.

INTERVENTIONS: Participants were randomized to 1 of 8 different groups as determined by 3 two-level intervention component combinations: intervention introduction method (mobile app vs therapist call), mindfulness meditation dose (once daily vs twice daily), and management of increasing symptoms (mobile app vs therapist call).

MAIN OUTCOMES AND MEASURES: The primary outcome was the 9-item Patient Health Questionnaire (PHQ-9) depression scale score (range, 0-27) at 1 month. Secondary outcomes included anxiety (7-item Generalized Anxiety Disorder) and posttraumatic stress disorder (Posttraumatic Stress Scale) symptoms at 1 and 3 months, adherence, and feasibility. General linear models were used to compare main effects and interactions of the components among intervention groups. A formal decisional framework was used to determine an optimized intervention version.

RESULTS: A total of 247 participants (mean [SD] age, 50.2 [15.4] years; 104 [42.1%] women) were randomized. Twice-daily meditation compared with once-daily meditation was associated with a 1.2 (95% CI, 0.04-2.4)-unit lower mean estimated PHQ-9 score at 1 month and a 1.5 (95% CI, 0.1-2.8)-unit lower estimated mean score at 3 months. The other 2 intervention components had no main effects on the PHQ-9. Across-group adherence was high (217 participants [87.9%] using the intervention at trial conclusion) and retention was strong (191 [77.3%] and 182 [73.7%] at 1 and 3 months, respectively).

CONCLUSIONS AND RELEVANCE: A mindfulness intervention for survivors of critical illness that included an app-based introduction, twice-daily guided meditation, and app-based management of increasing depression symptoms was optimal considering effects on psychological distress symptoms, adherence, and feasibility.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04038567.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Cox CE, Gallis JA, Olsen MK, et al. Mobile Mindfulness Intervention for Psychological Distress Among Intensive Care Unit Survivors: A Randomized Clinical Trial. JAMA Intern Med. 2024. PMID: 38805199. doi:10.1001/jamainternmed.2024.0823

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。